Trial completion date • Trial initiation date • Trial primary completion date
|
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • MGMT (6-O-methylguanine-DNA methyltransferase) • CD8 (cluster of differentiation 8)
|
IDH2 mutation • MGMT promoter methylation • IDH wild-type
|
Zynyz (retifanlimab-dlwr) • neoantigen DNA vaccine